Hide

FocusBar

Subscribe to Premium Member
Martin Whitman

Martin Whitman

Last Update: 2013-03-06

Number of Stocks: 39
Number of New Stocks: 3

Total Value: $2,290 Mil
Q/Q Turnover: 8%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:
Please Subscribe to see portfolio changes after 2013-01-31.

Plans start from as little as $299/year. 7-Day FREE TRIAL

Martin Whitman Latest Trades :



TickerCompanyDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALCO Alico Inc. 2008-01-31 Reduce-0.03%$35.62 - $44.17
($40.5)
$ 45.4912%Reduce -35.78%89,259
ACE ACE Ltd. 2008-01-31 Sold Out -0.05%$55.93 - $61.29
($58.8)
$ 91.6556%Sold Out0
STJ St. Jude Medical Inc... 2008-01-31 Sold Out -0.14%$38.95 - $43.07
($40.4)
$ 4716%Sold Out0
PRXL PAREXEL Internationa... 2008-01-31 Sold Out -0.26%$22.08 - $28.5
($24.5)
$ 46.7191%Sold Out0
SHLD Sears Holdings Corp. 2008-01-31 Sold Out -0.27%$89.43 - $120.97
($105.4)
$ 57.52-45%Sold Out0
PFE Pfizer Inc 2008-01-31 Sold Out -0.47%$21.84 - $23.68
($22.5)
$ 28.9629%Sold Out0
FCE.A Forest City Enterpri... 2007-10-31 Add0.14%$53.56 - $59.67
($56)
$ 20.12-64%Add 3.77%7,011,858
MTG MGIC Investment Corp... 2007-10-31 Buy 0.19%$19.35 - $36.6
($31.3)
$ 6.07-81%New holding, 1000000 sh.1,000,000
JOE The St. Joe Company 2007-10-31 Add0.19%$31.47 - $39.23
($34.4)
$ 21.11-39%Add 9.78%6,666,078
USG USG Corp. 2007-10-31 Add0.19%$35.9 - $40.12
($38.1)
$ 28.22-26%Add 20%3,000,000
CEN Ceridian Corp. 2007-10-31 Buy 0.25%$32.6 - $35.78
($34.5)
$ 14.445-58%New holding, 726718 sh.726,718
NBR Nabors Industries Lt... 2007-10-31 Add0.27%$27.56 - $31.67
($29.8)
$ 16.67-44%Add 11%10,090,000
CITGQ CIT Group Inc. 2007-10-31 Add0.34%$33.76 - $41.51
($37)
$ 0.25-99%Add 400%1,250,000
XEC Cimarex Energy Co. 2007-10-31 Add0.6%$35.11 - $39.23
($37.2)
$ 70.6490%Add 324.08%2,000,630
HLDVF HENDERSON LAND DEV 2007-10-31 Add0.62%$6.4 - $8.1
($7.4)
$ 7.11-4%Add 6.83%113,328,000
MBI MBIA Inc. 2007-10-31 Add0.66%$49.76 - $66.96
($58.4)
$ 15.35-74%Add 29.22%7,077,906
RDN Radian Group Inc. 2007-10-31 Add0.95%$11.94 - $24.05
($19.9)
$ 13.69-31%Add 316.52%10,359,150
ADS Alliance Data System... 2007-10-31 Buy 1.15%$72.9 - $80.6
($77.9)
$ 178.08129%New holding, 1486200 sh.1,486,200
WDGH Levitt Corp. 2007-10-31 Sold Out $10.05 - $30.15
($14.5)
$ 0.33-98%Sold Out0
COBK Colonial Bankshares ... 2007-10-31 Add$11.5 - $14.76
($12.34)
$ 13.59%Add 127.35%36,890
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

Martin Whitman's Profile:

Martin Whitman is Founder and Portfolio Manager of the Third Avenue Value Fund (TAVFX). Whitman is a 1949 graduate of Syracuse University, which recently renamed its School of Management after Whitman, after a large gift from him in June 2003. He is an adjunct faculty member at Yale School of Management.



Martin Whitman's Performance:

Average Annual Return of Third Avenue Value Fund
5 Yrs 10 Yrs Since Inception
-2% 6% 5.5%
» More Profile & Performance

Martin Whitman's Current Portfolio:

Ticker Shares Value ($1000)
WHLKF35,371,500199,311
PKX1,916,774156,140
HLDVF20,590,579148,149
BK5,412,879147,014
CVA7,193,557141,857
TYIDF3,806,700126,342
DVN2,200,889125,869
DSEEY20,741,300120,440
KEY12,558,132118,046
HNLGY18,534,000112,441
» More Current Portfolio

Martin Whitman's Sector Weightings:


SectorsSector Weightings (%)
Financial Services 24.2% 24.2%
Real Estate 23.9% 23.9%
Basic Materials 6.8% 6.8%
Energy 6.7% 6.7%
Technology 6.2% 6.2%
Consumer Cyclical 0% 0%
» More Sector Weightings

Martin Whitman's News:

» More Related News


Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK